Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
Sponsor: Priovant Therapeutics, Inc.
Summary
The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).
Official title: A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Active, Non-Infectious Intermediate-, Posterior-, and Panuveitis
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
371
Start Date
2024-09-11
Completion Date
2028-02-01
Last Updated
2026-01-12
Healthy Volunteers
No
Interventions
Brepocitinib PO QD
Brepocitinib PO QD
Placebo PO QD
Placebo PO QD
Locations (107)
Clinical Trial Site
Phoenix, Arizona, United States
Clinical Trial Site
Phoenix, Arizona, United States
Clinical Trial Site
Bakersfield, California, United States
Clinical Trial Site
Beverly Hills, California, United States
Clinical Trial Site
Fullerton, California, United States
Clinical Trial Site
Irvine, California, United States
Clinical Trial Site
La Jolla, California, United States
Clinical Trial Site
Los Angeles, California, United States
Clinical Trial Site
Los Angeles, California, United States
Clinical Trial Site
Modesto, California, United States
Clinical Trial Site
Sacramento, California, United States
Clinical Trial Site
Aurora, Colorado, United States
Clinical Trial Site
Denver, Colorado, United States
Clinical Trial Site
Fort Lauderdale, Florida, United States
Clinical Trial Site
St. Petersburg, Florida, United States
Clinical Trial Site
Chicago, Illinois, United States
Clinical Trial Site
Oak Park, Illinois, United States
Clinical Trial Site
Carmel, Indiana, United States
Clinical Trial Site
Prairie Village, Kansas, United States
Clinical Trial Site
Baltimore, Maryland, United States
Clinical Trial Site
Boston, Massachusetts, United States
Clinical Trial Site
Waltham, Massachusetts, United States
Clinical Trial Site
Ann Arbor, Michigan, United States
Clinical Trial Site
Detroit, Michigan, United States
Clinical Trial Site
Detroit, Michigan, United States
Clinical Trial Site
Minneapolis, Minnesota, United States
Clinical Trial Site
Rochester, Minnesota, United States
Clinical Trial Site
St Louis, Missouri, United States
Clinical Trial Site
Omaha, Nebraska, United States
Clinical Trial Site
Palisades Park, New Jersey, United States
NYU Langone Health
New York, New York, United States
Clinical Trial Site
Rochester, New York, United States
Clinical Trial Site
Durham, North Carolina, United States
Clinical Trial Site
Winston-Salem, North Carolina, United States
Clinical Trial Site
Cleveland, Ohio, United States
Clinical Trial Site
Cleveland, Ohio, United States
Clinical Trial Site
Columbus, Ohio, United States
Clinical Trial Site
Portland, Oregon, United States
Clinical Trial Site
Portland, Oregon, United States
Clinical Trial Site
Erie, Pennsylvania, United States
Clinical Trial Site
Philadelphia, Pennsylvania, United States
Clinical Trial Site
Philadelphia, Pennsylvania, United States
Clinical Trial Site
Greenville, South Carolina, United States
Clinical Trial Site
Nashville, Tennessee, United States
Clinical Trial Site
Austin, Texas, United States
Clinical Trial Site
Bellaire, Texas, United States
Clinical Trial Site
Dallas, Texas, United States
Clinical Trial Site
Houston, Texas, United States
Clinical Trial Site
Katy, Texas, United States
Clinical Trial Site
Plano, Texas, United States
Clinical Trial Site
Round Rock, Texas, United States
Clinical Trial Site
San Antonio, Texas, United States
Clinical Trial Site
Madison, Wisconsin, United States
Clinical Trial Site
Rosario, Santa Fe Province, Argentina
Clinical Trial Site
Buenos Aires, Argentina
Clinical Trial Site
Buenos Aires, Argentina
Clinical Trial Site
Buenos Aires, Argentina
Clinical Trial Site
Buenos Aires, Argentina
Clinical Trial Site
Sydney, New South Wales, Australia
Clinical Trial Site
East Melbourne, Victoria, Australia
Clinical Trial Site
Nedlands, Western Australia, Australia
Clinical Trial Site
Linz, Austria
Clinical Trial Site
Leuven, VI-Brabant, Belgium
Clinical Trial Site
Prague, Czechia
Clinical Trial Site
Mannheim, Baden-Wurttemberg, Germany
Clinical Trial Site
Bonn, North Rhine-Westphalia, Germany
Clinical Trial Site
Düsseldorf, North Rhine-Westphalia, Germany
Clinical Trial Site
Münster, North Rhine-Westphalia, Germany
Clinical Trial Site
Münster, North Rhine-Westphalia, Germany
Clinical Trial Site
Kiel, Germany
Clinical Trial Site
Mainz, Germany
Clinical Trial Site
Thessaloniki, Greece
Clinical Trial Site
Pécs, Baranya, Hungary
Clinical Trial Site
Debrecen, Hajdú-Bihar, Hungary
Clinical Trial Site
Budapest, Pest County, Hungary
Clinical Trial Site
Budapest, Hungary
Clinical Trial Site
Ashkelon, Israel
Clinical Trial Site
Haifa, Israel
Clinical Trial Site
Haifa, Israel
Clinical Trial Site
Holon, Israel
Clinical Trial Site
Jerusalem, Israel
Clinical Trial Site
Jerusalem, Israel
Clinical Trial Site
Kfar Saba, Israel
Clinical Trial Site
Poria – Neve Oved, Israel
Clinical Trial Site
Tel Aviv, Israel
Clinical Trial Site
Tel Aviv, Israel
Clinical Trial Site
Perugia, Umbria, Italy
Clinical Trial Site
Milan, Italy
Clinical Trial Site
Reggio Emilia, Italy
Clinical Trial Site
Roma, Italy
Clinical Trial Site
Barcelona, Catalonia, Spain
Clinical Trial Site
Barcelona, Spain
Clinical Trial Site
Madrid, Spain
Clinical Trial Site
Madrid, Spain
Clinical Trial Site
Valladolid, Spain
Clinical Trial Site
London, England, United Kingdom
Clinical Trial Site
London, England, United Kingdom
Clinical Trial Site
Maidstone, Kent, United Kingdom
Clinical Trial Site
Middlesbrough, North Yorkshire, United Kingdom
Clinical Trial Site
Oxford, Oxfordshire, United Kingdom
Clinical Trial Site
Sheffield, South Yorkshire, United Kingdom
Clinical Trial Site
Birmingham, West Midlands, United Kingdom
Clinical Trial Site
Bradford, Yorkshire, United Kingdom
Clinical Trial Site
Birmingham, United Kingdom
Clinical Trial Site
Bristol, United Kingdom
Clinical Trial Site
Liverpool, United Kingdom
Clinical Trial Site
Manchester, United Kingdom